| Literature DB >> 33960039 |
Joanna Lazniewska1, Mark Agostino2, Shane M Hickey1, Emma Parkinson-Lawrence1, Stefano Stagni3, Massimiliano Massi4, Douglas A Brooks1, Sally E Plush1.
Abstract
Re(I) complexes have potential in biomedical sciences as imaging agents, diagnostics and therapeutics. Thus, it is crucial to understand how Re(I) complexes interact with carrier proteins, like serum albumins. Here, two neutral Re(I) complexes were used (fac-[Re(CO)3 (1,10-phenanthroline)L], in which L is either 4-cyanophenyltetrazolate (1) or 4-methoxycarbonylphenyltetrazole ester (2), to study the interactions with bovine serum albumin (BSA). Spectroscopic measurements, calculations of thermodynamic and Förster resonance energy transfer parameters, as well as molecular modelling, were performed to study differential binding between BSA and complex 1 and 2. Induced-fit docking combined with quantum-polarised ligand docking were employed in what is believed to be a first for a Re(I) complex as a ligand for BSA. Our findings provide a basis for other molecular interaction studies and suggest that subtle functional group alterations at the terminal region of the Re(I) complex have a significant impact on the ability of this class of compounds to interact with BSA.Entities:
Keywords: UV/Vis spectroscopy; bovine serum albumin; fluorescence spectroscopy; molecular modelling; rhenium complexes
Year: 2021 PMID: 33960039 DOI: 10.1002/chem.202101307
Source DB: PubMed Journal: Chemistry ISSN: 0947-6539 Impact factor: 5.236